The Oxford Healthcare Values Partnership

Session 4: Equity and commissioning - Richard Sullivan A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 4: Equity and commissioning - Muir Gray A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 3: Data sharing and participation - Jonathan Montgomery A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 3: Data sharing and participation - Anna Middleton A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 3: Data sharing and participation - Mark Lawler A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 2: The human person and the communication of risk - Sian Rees A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 2: The human person and the communication of risk - Alastair Kent A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 2: The human person and the communication of risk - Joshua Hordern A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 1: The promise and the hype of 'personalised medicine' - John Tooke A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).

Session 1: The promise and the hype of 'personalised medicine' - Steve Sturdy A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).